Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
42
Number of overlapping holdings
35.6%
% of XBI's 119 holdings also in BBP
68.9%
% of BBP's 65 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
GILEAD SCIENCES INC | 2.4% | 2.1% | 2.1% |
|
AMGEN INC | 2.4% | 2.0% | 2.0% |
|
EXELIXIS INC | 1.9% | 1.8% | 1.8% |
|
MADRIGAL PHARMACEUTICALS, INC. | 2.3% | 1.8% | 1.8% |
|
BIOMARIN PHARMACEUTICAL INC | 2.2% | 1.8% | 1.8% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to BBP
|
NATERA INC | 2.5% |
|
ABBVIE INC | 2.4% |
|
EXACT SCIENCES CORP | 2.3% |
|
VAXCYTE, INC. | 2.1% |
|
CYTOKINETICS INC | 1.5% |
|
REVOLUTION MEDICINES, INC. | 1.4% |
 |
ALKERMES PLC | 1.1% |
|
ALNYLAM PHARMACEUTICALS INC | 1.1% |
|
NEUROCRINE BIOSCIENCES INC | 1.1% |
|
VIKING THERAPEUTICS, INC. | 1.1% |
XBI Underweight Relative to BBP
|
INTRA-CELLULAR THERAPIES INC | -2.6% |
|
BEIGENE LTD. SPONSORED ADR | -2.3% |
 |
ZAI LAB LTD. UNSPONSORED ADR | -2.2% |
|
SAGE THERAPEUTICS INC | -2.2% |
|
AXSOME THERAPEUTICS, INC. | -2.1% |
|
ASCENDIS PHARMA A/S | -1.8% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -1.7% |
|
LIGAND PHARMACEUTICALS-CL B | -1.7% |
|
LEGEND BIOTECH CORPORATION SPONSORED | -1.6% |
 |
IMMUNOCORE HOLDINGS PLC SPONSORED AD | -1.6% |